Lysosomal acid lipase deficiency
עודכן לאחרונה 18 Aug 2020
עומד בהנחיות העריכה של Patient
- הורדהורד
- שתף
- Language
- דיון
- Ask Patient
- גרסת שמע
- הוסף למקורות מועדפים בגוגל
Lysosomal acid lipase deficiency is an inherited condition characterised by problems with the breakdown and use of fats and cholesterol in the body (lipid metabolism). In affected individuals, harmful amounts of fats (lipids) accumulate in cells and tissues throughout the body, which typically causes liver disease. There are two forms of the condition. The most severe and rarest form begins in infancy. The less severe form can begin from childhood to late adulthood.
בחירות וידאו עבור Genetic conditionsספריית סרטונים
תיאור
Lysosomal acid lipase deficiency is an inherited condition characterised by problems with the breakdown and use of fats and cholesterol in the body (lipid metabolism). In affected individuals, harmful amounts of fats (lipids) accumulate in cells and tissues throughout the body, which typically causes liver disease. There are two forms of the condition. The most severe and rarest form begins in infancy. The less severe form can begin from childhood to late adulthood.
In the severe, early-onset form of lysosomal acid lipase deficiency, lipids accumulate throughout the body, particularly in the liver, within the first weeks of life. This accumulation of lipids leads to several health problems, including an enlarged liver and spleen (hepatosplenomegaly), poor weight gain, a yellow tint to the skin and the whites of the eyes (jaundice), vomiting, diarrhea, fatty stool (steatorrhea), and poor absorption of nutrients from food (malabsorption). In addition, affected infants often have calcium deposits in small hormone-producing glands on top of each kidney (adrenal glands), low amounts of iron in the blood (anaemia), and developmental delay. Scar tissue quickly builds up in the liver, leading to liver disease (cirrhosis). Infants with this form of lysosomal acid lipase deficiency develop multi-organ failure and severe malnutrition and generally do not survive past 1 year.
In the later-onset form of lysosomal acid lipase deficiency, signs and symptoms vary and usually begin in mid-childhood, although they can appear anytime up to late adulthood. Nearly all affected individuals develop an enlarged liver (hepatomegaly); an enlarged spleen (splenomegaly) may also occur. About two-thirds of individuals have liver fibrosis, eventually leading to cirrhosis. Approximately one-third of individuals with the later-onset form have malabsorption, diarrhea, vomiting, and steatorrhea. Individuals with this form of lysosomal acid lipase deficiency may have increased liver enzymes and high cholesterol levels, which can be detected with blood tests.
Some people with this later-onset form of lysosomal acid lipase deficiency develop an accumulation of fatty deposits on the artery walls (atherosclerosis). Although these deposits are common in the general population, they usually begin at an earlier age in people with lysosomal acid lipase deficiency. The deposits narrow the arteries, increasing the chance of heart attack or stroke. The expected lifespan of individuals with later-onset lysosomal acid lipase deficiency depends on the severity of the associated health problems.
The two forms of lysosomal acid lipase deficiency were once thought to be separate disorders. The early-onset form was known as Wolman disease, and the later-onset form was known as cholesteryl ester storage disease. Although these two disorders have the same genetic cause and are now considered to be forms of a single condition, these names are still sometimes used to distinguish between the forms of lysosomal acid lipase deficiency.
Inheritance patterns
The source lists the following possible inheritance patterns: Autosomal recessive. More than one pattern can apply in different cases.
Related genes
Other names
Acid esterase deficiency
Acid lipase deficiency
Familial visceral xanthomatosis
Familial xanthomatosis
LAL deficiency
LIPA deficiency
Primary familial xanthomatosis
Primary familial xanthomatosis with adrenal calcification
Related patient information and medicines

Patient information leaflet
תופעות לוואי נפוצות של הריון
הריון presents the body with a number of challenges, many of which can produce symptoms and cause problems. Many side effects of pregnancy are not serious for mother or baby, although complaints like nausea, vomiting, acid reflux and constipation can be very unple... What conditions may affect my pregnancy. Dr Shazia Malik Pregnancy is not an.

Patient information leaflet
עיכול לקוי וצרבת בהריון
Indigestion (dyspepsia) occurs at some point in around half of all pregnant women. It is usually due to acid reflux from the stomach into the gullet (oesophagus). What is indigestion and acid reflux. Indigestion (dyspepsia) is a term which includes a group of symptoms (detailed below) that come from a problem in your upper gut. The gut.

Patient information leaflet
ריפלוקס חומצי ואזופגיטיס
מתי acid from the stomach leaks up into the oesophagus (tube carrying the food from the mouth to the stomach) the condition is known as acid reflux. This may cause heartburn and other symptoms. What is acid reflux. Dr Sarah Jarvis MBE, GP and Clinical Director of Patient.info When acid from the stomach leaks up into the gullet (oesophagus), the.

Patient information leaflet
האם אני יכול לקחת חומצה פולית ופרע מחורר יחד?
There is no known significant interaction between folic acid and St John's wort. It is generally considered safe to take these two together. Why this happens חומצה פולית מטופל? a water-soluble B vitamin, while St John's wort הוא herbal remedy primarily used for low mood. They are processed by different pathways in the body and do not interfere with.

Patient information leaflet
האם אני יכול לקחת חומצה פולית וגלוקוזאמין יחד?
למה זה קורה Folic acid (a B vitamin) and glucosamine (an amino sugar) are processed by the body through different pathways. They do not compete for absorption in the gut, nor do they interfere with how the liver ... Using other medicines Taking multiple medicines. Our בודק אינטראקציות בין תרופות helps you check whether your prescriptions,.

Patient information leaflet
האם אני יכול לקחת קוהוש שחור וחומצה פולית יחד?
Black cohosh is primarily broken down by liver enzymes (specifically ה CYP450 system), while חומצה פולית מטופל? a water-soluble B vitamin that follows a separate metabolic route. They do not interfere with each other's a... Using other medicines Taking multiple medicines. Our בודק אינטראקציות בין תרופות helps you check whether your prescriptions,.
קריאה נוספת והפניות
- Lysosomal acid lipase deficiency; MedlinePlus, National Library of Medicine.
- Burton BK, Deegan PB, Enns GM, Guardamagna O, Horslen S, Hovingh GK, Lobritto SJ, Malinova V, McLin VA, Raiman J, Di Rocco M, Santra S, Sharma R, Sykut-Cegielska J, Whitley CB, Eckert S, Valayannopoulos V, Quinn AG. Clinical Features of Lysosomal Acid Lipase Deficiency. J Pediatr Gastroenterol Nutr. 2015 Dec;61(6):619-25. doi: 10.1097/MPG.0000000000000935.
- Reiner Z, Guardamagna O, Nair D, Soran H, Hovingh K, Bertolini S, Jones S, Coric M, Calandra S, Hamilton J, Eagleton T, Ros E. Lysosomal acid lipase deficiency--an under-recognized cause of dyslipidaemia and liver dysfunction. Atherosclerosis. 2014 Jul;235(1):21-30. doi: 10.1016/j.atherosclerosis.2014.04.003. Epub 2014 Apr 15.
- Saito S, Ohno K, Suzuki T, Sakuraba H. Structural bases of Wolman disease and cholesteryl ester storage disease. Mol Genet Metab. 2012 Feb;105(2):244-8. doi: 10.1016/j.ymgme.2011.11.004. Epub 2011 Nov 20.
- Zhang B, Porto AF. Cholesteryl ester storage disease: protean presentations of lysosomal acid lipase deficiency. J Pediatr Gastroenterol Nutr. 2013 Jun;56(6):682-5. doi: 10.1097/MPG.0b013e31828b36ac.
שתפו את מחשבותיכם או חוויותיכם עם אחרים ב קהילות המטופלים שלנו.
הירשמו לניוזלטר של פיישנט
המנה השבועית שלך של עצות בריאות ברורות ואמינות - נכתבה כדי לעזור לך להרגיש מעודכן, בטוח ובשליטה.
על ידי הרשמה אתה מקבל את שלנו מדיניות הפרטיות שלנו. באפשרותך לבטל את המנוי בכל עת. לעולם לא נמכור את הנתונים שלך.

